Understanding Alpha One Antitrypsin: A Comprehensive Guide

Alpha One Antitrypsin (AAT) is a crucial protein produced primarily in the liver.


Understanding Alpha One Antitrypsin: A Vital Protective Protein

Alpha One Antitrypsin (AAT) is a crucial protein produced primarily in the liver. Its main role in the human body is to protect tissues from damage by enzymes, particularly elastase, an enzyme released by white blood cells (neutrophils) during inflammation or infection. Without sufficient AAT, these enzymes can aggressively attack and break down healthy tissues, especially in the lungs, leading to serious medical conditions.

What is Alpha One Antitrypsin?

AAT belongs to a family of proteins called serpins (serine protease inhibitors). Its primary function is to neutralize potent enzymes, such as neutrophil elastase, which are vital for fighting infections but can cause significant damage if unchecked. The lungs, being constantly exposed to environmental irritants and potential infections, rely heavily on AAT for protection against this enzymatic destruction.

Alpha One Antitrypsin Deficiency (AATD)

Alpha One Antitrypsin Deficiency (AATD) is a hereditary genetic disorder characterized by low levels or abnormal function of AAT in the blood. This deficiency can lead to a significant lack of protection for the lungs and, in some cases, can also cause liver disease. AATD is passed down through families, meaning individuals inherit two copies of the AAT gene, one from each parent. Mutations in these genes can lead to the production of dysfunctional AAT protein or insufficient quantities of it.

Genetic Basis of AATD

The most common forms of AATD involve specific mutations in the SERPINA1 gene. The normal gene is referred to as M. Common deficient alleles include S and Z. Individuals who inherit two copies of the Z allele (ZZ) typically have the most severe deficiency, while those with one M and one Z allele (MZ) are carriers and may have moderately reduced AAT levels, sometimes experiencing milder symptoms or being asymptomatic. Other less common mutations also exist.

Conditions Associated with AATD

The primary conditions linked to AATD include:


  • Emphysema: The most common manifestation, characterized by the progressive destruction of the small air sacs (alveoli) in the lungs. This leads to shortness of breath, wheezing, and chronic cough, often resembling chronic obstructive pulmonary disease (COPD).

  • Liver Disease: In some individuals, particularly children, the abnormal AAT protein produced by the liver can accumulate within liver cells, leading to inflammation, scarring (cirrhosis), and liver failure.

  • Panniculitis: A rare skin condition causing tender, inflamed lumps under the skin.

Symptoms of Alpha One Antitrypsin Deficiency

Symptoms can vary widely depending on the severity of the deficiency and which organs are affected. Many individuals with AATD may not experience symptoms until adulthood, or their symptoms might be misdiagnosed as other common conditions.

Lung Symptoms


  • Shortness of breath, especially with exertion

  • Chronic cough with or without mucus production

  • Wheezing

  • Recurrent respiratory infections (bronchitis, pneumonia)

  • Fatigue

  • Unintended weight loss

Liver Symptoms

Liver disease from AATD is more common in infants and children but can also affect adults. Symptoms may include:


  • Jaundice (yellowing of the skin and eyes)

  • Swelling of the abdomen (ascites) or legs

  • Fatigue

  • Easy bruising or bleeding

  • Poor growth in infants

Diagnosing Alpha One Antitrypsin Deficiency

Early diagnosis of AATD is crucial for managing the condition and preventing further organ damage. Diagnosis typically involves:


  • Blood Test: A simple blood test can measure the level of AAT in the blood. Low levels indicate a potential deficiency.

  • Genetic Testing: If AAT levels are low, genetic testing can identify the specific mutations in the SERPINA1 gene, confirming the diagnosis and determining the specific genotype (e.g., PiZZ, PiMZ).

  • Pulmonary Function Tests (PFTs): These tests assess lung function and can help determine the extent of lung damage.

  • Liver Function Tests and Imaging: Blood tests for liver enzymes and imaging studies (ultrasound, CT scan, MRI) can assess liver health.

Treatment and Management

While there is currently no cure for AATD, various treatments and management strategies can help control symptoms, slow disease progression, and improve quality of life.

Augmentation Therapy

For individuals with AATD who have emphysema, augmentation therapy is a common treatment. This involves intravenous (IV) infusions of purified human AAT protein, typically administered weekly. The goal is to raise the AAT levels in the blood and lungs, providing protection against further tissue damage. This therapy does not reverse existing lung damage but can help slow its progression.

Lifestyle Modifications


  • Smoking Cessation: Quitting smoking is the single most important intervention for individuals with AATD, as smoking dramatically accelerates lung damage.

  • Avoidance of Irritants: Minimizing exposure to lung irritants such as dust, pollution, and chemical fumes is important.

  • Vaccinations: Receiving recommended vaccinations, particularly for influenza and pneumonia, can help prevent respiratory infections that can exacerbate lung damage.

Symptomatic Treatments

Similar to standard COPD management, individuals with AATD may use:


  • Bronchodilators to open airways.

  • Corticosteroids to reduce inflammation.

  • Oxygen therapy for severe breathing difficulties.

  • Pulmonary rehabilitation to improve lung function and exercise tolerance.

Liver Management

Management of liver disease associated with AATD focuses on supportive care, monitoring liver function, and, in severe cases, liver transplantation.

Living with Alpha One Antitrypsin Deficiency

Living with AATD requires proactive management and a strong commitment to health. Regular follow-ups with specialists, adherence to treatment plans, and participation in support groups can significantly enhance well-being. Understanding the genetic nature of the condition also allows for family screening, which can lead to earlier diagnosis and intervention for other affected family members.